Trade Summary

3 days ago, Bedrosian Camille L, serving as Chief Medical Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 6,461 shares at $14.58 per share, for a total transaction value of $94,205.00. Following this transaction, Bedrosian Camille L now holds 169,295 shares of AMLX.

This sale represents a 4.00% decrease in Bedrosian Camille L's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Amylyx Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.